Physician profile
Michael D Hill
NPI 1174568349
$40,931.66
in general payments reported to CMS, 2019-2025
12 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $16K · 2021: $11K · 2022: $5,757 · 2023: $7,275 · 2024: $172 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,250 · Travel and Lodging: $1,586 · Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,250.00 |
| Travel and Lodging | $1,585.72 |
| Food and Beverage | $714.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21,251.86 | 2021-2023 | |
| Allergan, INC. | $18,767.46 | 2019-2021 | |
| Tris Pharma INC | $310.36 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Sunovion Pharmaceuticals INC. | $151.69 | 2019-2020 | |
| Alkermes, INC. | $133.00 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $116.73 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $74.30 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $55.28 | 2019 | |
| Shire North American Group INC | $20.70 | 2019 | |
| Lundbeck LLC | $19.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.28 | 2019 | |
| Vanda Pharmaceuticals INC. | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.